Welcome to our dedicated page for Broadcom SEC filings (Ticker: AVGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Broadcom’s filings are a maze of semiconductor yield metrics, software license roll-forwards, and acquisition footnotes that can stretch well past 300 pages. Finding when networking chip demand shifts or where software recurring revenue is booked often means scrolling line by line.
Stock Titan solves that problem. Our AI-powered summaries break down every Broadcom quarterly earnings report 10-Q filing, highlight segment revenue in plain English, and flag supply-chain risks in seconds. Need to monitor Broadcom insider trading Form 4 transactions? Real-time alerts surface executive stock moves the moment they hit EDGAR, giving you the context traditional feeds miss.
You’ll find everything in one place:
- 10-K annual report insights—Broadcom annual report 10-K simplified for quick strategy checks
- 8-K material events with clear explanations—Broadcom 8-K material events explained
- Proxy statement highlights for Broadcom proxy statement executive compensation
- Side-by-side trend graphs for each Broadcom earnings report filing analysis
- Instant push notices on Broadcom Form 4 insider transactions real-time
Whether you’re comparing wireless chipset margins quarter over quarter or understanding Broadcom SEC documents with AI, our platform trims hours of manual reading. Investors track cash-flow impacts from multi-billion-dollar acquisitions, auditors pinpoint goodwill adjustments, and traders follow Broadcom executive stock transactions Form 4 before market-moving announcements—all without decoding legal jargon. Complex filings made clear, updated the moment Broadcom hits “submit.”
Broadcom Inc. (AVGO) director Justine F. Page sold 800 shares of Broadcom common stock at $307.46 per share on 08/14/2025 under a pre-established Rule 10b5-1 trading plan. After the sale the reporting person beneficially owned 23,782 shares, which the filing notes include 1,602 restricted stock units. The transaction was reported on Form 4 and executed pursuant to a trading plan adopted January 9, 2025.
The Form 4 identifies the reporting person as a director and shows the sale was made under code S(1) with an attorney-in-fact signing the filing on behalf of the reporting person. No derivative transactions or other securities classes are reported.
Form 144 notice for Broadcom Inc. (AVGO): an executive or insider plans to sell 800 shares of Common stock through Fidelity Brokerage Services with an aggregate market value of $245,968 and an approximate sale date of 08/14/2025. The filing shows those 800 shares were acquired from the issuer as restricted stock vesting—570 shares on 04/03/2024 and 230 shares on 04/21/2025—and were received as compensation. The issuer has 4,703,470,979 shares outstanding per the form. The filing also discloses three recent sales by Justine Page of 800 shares each on 05/14/2025, 06/16/2025, and 07/14/2025 with gross proceeds of $184,152, $200,280, and $219,440, respectively. The filer certifies no undisclosed material adverse information.
Broadcom Inc. (AVGO) – Form 144 filing overview: A person affiliated with Broadcom has filed a Form 144 to give notice of an intended sale of 49,670 shares of Broadcom common stock. The shares have an aggregate market value of $13.82 million and are expected to be sold on or about 07 July 2025 through Northern Trust Securities, Inc. on the NASDAQ exchange. The filer originally acquired the shares on 14 Aug 1991 as “Founded Shares” from H&S Investments I, LP. The notice indicates that the seller has not sold any Broadcom shares during the past three months.
The filing is purely a regulatory notice; it does not disclose any operational or financial performance data for Broadcom. With approximately 4.70 billion shares outstanding (per the filing), the proposed sale represents an immaterial fraction of shares (<0.001%). Form 144 also contains the required representation that the seller is unaware of undisclosed material adverse information. Investors typically view such small-scale Form 144 sales as routine personal liquidity events rather than signals of fundamental change at the issuer.
FAQ
What is the current stock price of Broadcom (AVGO)?
What is the market cap of Broadcom (AVGO)?
